PET/CT预测肝细胞癌肝移植术后复发的研究进展  

Research progress in prediction of hepatocellular carcinoma recurrence after liver transplantation using PET/CT

作　　者：李世昌 郭艾楠 张芳[1] 魏玲格[1] 傅鹏[1] Li Shichang;Guo Ainan;Zhang Fang;Wei Lingge;Fu Peng(Department of Nuclear Medicine,the Third Hospital of Hebei Medical University,Shijiazhuang 050051,China;Department of Physical Examination,the Second Hospital of Hebei Medical University,Shijiazhuang 050000,China)

机构地区：[1]河北医科大学第三医院核医学科,石家庄050051 [2]河北医科大学第二医院体检中心,石家庄050000

出　　处：《中华核医学与分子影像杂志》2024年第10期633-636,共4页Chinese Journal of Nuclear Medicine and Molecular Imaging

摘　　要：随着肝移植技术的日益成熟及术后管理水平的提高,肝移植已成为治疗肝细胞癌(HCC)的重要手段之一。术后复发是导致治疗失败的主要原因。因此,准确预测HCC肝移植患者术后复发风险具有重要的临床意义。PET/CT能够从分子水平反映细胞代谢及靶器官功能变化,其肿瘤代谢负荷参数已被纳入肝移植术后评估体系,并具有较好的预后评估价值。该文对PET/CT预测HCC患者肝移植术后复发的研究进行综述。With the increasing maturity of liver transplantation technology and the improvement of postoperative management,liver transplantation has become one of the important means for treating hepatocellular carcinoma(HCC).However,the postoperative recurrence is the main reason for treatment failure.Therefore,it is of great clinical significance to accurately predict the risk of postoperative recurrence in patients undergoing liver transplantation for HCC.PET/CT can reflect cellular metabolism and function changes in target organ at the molecular level.The tumor metabolic burden parameters of PET/CT have been included in the post-transplant evaluation system for liver transplantation and have good prognostic value.This article provides a review of prediction of HCC recurrence after liver transplantation using PET/CT.

关 键 词：癌 肝细胞 肝移植 复发 正电子发射断层显像术 体层摄影术 X线计算机 发展趋势 

分 类 号：R735.7[医药卫生—肿瘤] R730.44[医药卫生—临床医学]